Literature DB >> 11784700

Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus.

D W Cope1, G Maccaferri, L F Márton, J D B Roberts, P M Cobden, P Somogyi.   

Abstract

Two types of GABAergic interneurone are known to express cholecystokinin-related peptides in the isocortex: basket cells, which preferentially innervate the somata and proximal dendrites of pyramidal cells; and double bouquet cells, which innervate distal dendrites and dendritic spines. In the hippocampus, cholecystokinin immunoreactivity has only been reported in basket cells. However, at least eight distinct GABAergic interneurone types terminate in the dendritic domain of CA1 pyramidal cells, some of them with as yet undetermined neurochemical characteristics. In order to establish whether more than one population of cholecystokinin-expressing interneurone exist in the hippocampus, we have performed whole-cell current clamp recordings from interneurones located in the stratum radiatum of the hippocampal CA1 region of developing rats. Recorded neurones were filled with biocytin to reveal their axonal targets, and were tested for the presence of pro-cholecystokinin immunoreactivity. The results show that two populations of cholecystokinin-immunoreactive interneurones exist in the CA1 area (n=15 positive cells). Cholecystokinin-positive basket cells (53%) preferentially innervate stratum pyramidale and adjacent strata oriens and radiatum. A second population of cholecystokinin-positive cells, previously described as Schaffer collateral-associated interneurones [Vida et al. (1998) J. Physiol. 506, 755-773], have axons that ramify almost exclusively in strata radiatum and oriens, overlapping with the Schaffer collateral/commissural pathway originating from CA3 pyramidal cells. Two of seven of the Schaffer collateral-associated cells were also immunopositive for calbindin. Soma position and orientation in stratum radiatum, the number and orientation of dendrites, and the passive and active membrane properties of the two cell populations are only slightly different. In addition, in stratum radiatum and its border with lacunosum of perfusion-fixed hippocampi, 31.6+/-3.8% (adult) or 26.8+/-2.9% (postnatal day 17-20) of cholecystokinin-positive cells were also immunoreactive for calbindin. Therefore, at least two populations of pro-cholecystokinin-immunopositive interneurones, basket and Schaffer collateral-associated cells, exist in the CA1 area of the hippocampus, and are probably homologous to cholecystokinin-immunopositive basket and double bouquet cells in the isocortex. It is not known if the GABAergic terminals of double bouquet cells are co-aligned with specific glutamatergic inputs. However, in the hippocampal CA1 area, it is clear that the terminals of Schaffer collateral-associated cells are co-stratified with the glutamatergic input from the CA3 area, with as yet unknown functional consequences. The division of the postsynaptic neuronal surface by two classes of GABAergic cell expressing cholecystokinin in both the hippocampus and isocortex provides further evidence for the uniform synaptic organisation of the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784700     DOI: 10.1016/s0306-4522(01)00440-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  60 in total

1.  Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus.

Authors:  Sang-Hun Lee; Csaba Földy; Ivan Soltesz
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Cell type dependence and variability in the short-term plasticity of EPSCs in identified mouse hippocampal interneurones.

Authors:  Attila Losonczy; Limei Zhang; Ryuichi Shigemoto; Peter Somogyi; Zoltan Nusser
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

3.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

Authors:  Attila Losonczy; Agota A Biró; Zoltan Nusser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

4.  Regulation of neuronal input transformations by tunable dendritic inhibition.

Authors:  Matthew Lovett-Barron; Gergely F Turi; Patrick Kaifosh; Peter H Lee; Frédéric Bolze; Xiao-Hua Sun; Jean-François Nicoud; Boris V Zemelman; Scott M Sternson; Attila Losonczy
Journal:  Nat Neurosci       Date:  2012-01-15       Impact factor: 24.884

Review 5.  Neurogliaform cells and other interneurons of stratum lacunosum-moleculare gate entorhinal-hippocampal dialogue.

Authors:  Marco Capogna
Journal:  J Physiol       Date:  2010-12-06       Impact factor: 5.182

6.  Hippogate: a break-in from entorhinal cortex.

Authors:  Allyson Alexander; Ivan Soltesz
Journal:  Nat Neurosci       Date:  2016-02-15       Impact factor: 24.884

Review 7.  Defined types of cortical interneurone structure space and spike timing in the hippocampus.

Authors:  Peter Somogyi; Thomas Klausberger
Journal:  J Physiol       Date:  2004-11-11       Impact factor: 5.182

8.  Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.

Authors:  Axel Neu; Csaba Földy; Ivan Soltesz
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

9.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

10.  Comparison of Ca2+ transients and [Ca2+]i in the dendrites and boutons of non-fast-spiking GABAergic hippocampal interneurons using two-photon laser microscopy and high- and low-affinity dyes.

Authors:  Máté Kisfali; Tibor Lrincz; E Sylvester Vizi
Journal:  J Physiol       Date:  2013-08-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.